How has been the historical performance of Mardia Samyoung?
Mardia Samyoung has shown stagnant revenue with zero net sales from Mar'20 to Mar'25, but reported a turnaround in Mar'25 with an operating profit of 1.20 Cr and positive earnings per share of 1.72, contrasting previous losses.
Answer:The historical performance of Mardia Samyoung shows a consistent lack of revenue generation over the years, with net sales remaining at 0.00 Cr from Mar'20 to Mar'25. The only notable income was from other operating income, which peaked at 0.32 Cr in Mar'16 but dropped to 0.00 Cr by Mar'25. Total operating income followed a similar trend, with a high of 0.33 Cr in Mar'16 and falling to 0.00 Cr by Mar'25. The company's expenditures have fluctuated, with total expenditure excluding depreciation reaching a high of 1.56 Cr in Mar'25, leading to an operating profit (PBDIT) of 1.20 Cr in the same year, a significant turnaround from previous years where losses were recorded. Profit before tax and profit after tax also turned positive in Mar'25 at 1.20 Cr, contrasting with losses in prior years. The earnings per share (EPS) improved to 1.72 in Mar'25 from negative values in earlier years. Breakdown:
Mardia Samyoung's financial history reveals a challenging trajectory, marked by zero net sales from Mar'20 to Mar'25, indicating a stagnant revenue stream. The company experienced a slight increase in other operating income in earlier years, but this dwindled to nothing by Mar'25. Total operating income peaked in Mar'16 before declining to zero, while total expenditure saw a rise to 1.56 Cr in Mar'25, contributing to a notable operating profit of 1.20 Cr in the same year, a stark contrast to the losses recorded in previous years. The company finally reported a profit before tax and profit after tax of 1.20 Cr in Mar'25, showcasing a significant improvement from the losses of up to 1.07 Cr in Mar'15. The earnings per share also reflected this positive shift, rising to 1.72 in Mar'25 from negative figures in prior years, suggesting a potential recovery in financial health.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
